F-star Therapeutics, Inc. FSTX
7.12 0.00 (+0.00%)
At closeMar 8, 2023, 4:00 PM EST
7.11 Day range 7.12
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 7.00
Ratings (-1m) 4 0 buy · 4 hold · 0 sell
- Strong buy0
- Buy0
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 4
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.39 | -0.46 – -0.32 | 0.48 | -181.2% | 0 | 0.0% | 2 |
| Next quarter | -0.76 | -0.76 – -0.76 | -0.57 | -33.3% | 0 | 0.0% | 1 |
| Current year | -2.47 | -2.61 – -2.33 | -1.88 | -31.4% | 4.34M | -79.5% | 2 |
| Next year | -3.44 | -4.66 – -2.23 | -2.47 | -39.3% | 2.50M | -42.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 15, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 24, 2022 | SVB Leerink | Downgrade | Outperform | Market Perform |
| May 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 17, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 17, 2021 | SVB Leerink | Maintained | — | Outperform |
| Jul 8, 2021 | SVB Leerink | Initiated | — | Outperform |
| Jun 9, 2021 | B. Riley Securities | Initiated | — | Buy |
| May 18, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 16, 2021 | Oppenheimer | Initiated | — | Outperform |
| Apr 8, 2021 | William Blair | Initiated | — | Outperform |
| Mar 24, 2021 | Laidlaw & Co. | Initiated | — | Buy |
| Mar 1, 2021 | HC Wainwright & Co. | Initiated | — | Buy |